Skip to main content
. 2014 Sep 4;106(9):dju240. doi: 10.1093/jnci/dju240

Table 1.

Participant characteristics by study and case-control status*

Study Case-control status Number of participants Mean (SD) age at recruitment, y Mean (SD) BMI, kg/m2 Married or cohabiting, % Higher education, % Current smokers, % Mean (SD) intake of alcohol, g/d
CARET Case patients 666 60.0 (5.7) 28.2 (4.3) 81.7 28.1 51.7 17.6 (25.3)
Control patients 1282 59.7 (5.8) 28.2 (4.4) 81.7 23.9 52.3 15.6 (26.0)
EPIC Case patients 964 59.9 (5.8) 26.6 (3.4) 88.8 27.0 24.4 21.6 (24.8)
Control patients 1063 59.6 (5.7) 26.9 (3.6) 88.8 22.7 29.9 21.2 (24.4)
MCCS Case patients 549 60.9 (6.4) 27.2 (3.5) 80.2 22.6 9.7 19.1 (24.4)
Control patients 1019 58.4 (7.2) 27.2 (3.7) 81.2 22.5 13.2 21.1 (25.8)
MEC Case patients 377 68.6 (7.1) 26.6 (4.1) 76.9 32.2 15.0 23.4 (42.8)
Control patients 732 68.5 (7.2) 27.0 (4.2) 78.8 31.1 12.1 21.8 (38.6)
PCPT Case patients 995 63.3 (5.5) 27.4 (4.1) 87.5 39.4 6.7 9.7 (16.1)
Control patients 995 63.3 (5.5) 27.6 (4.0) 87.7 37.1 7.5 9.0 (13.9)
PHS Case patients 488 58.2 (7.8) 24.7 (2.5) N/A 100.0 7.6 7.3 (6.1)
Control patients 499 58.1 (7.6) 24.4 (2.5) N/A 100.0 7.4 7.0 (6.1)
SELECT Case patients 1059 63.8 (6.1) 28.6 (4.4) 83.5 56.0 5.1 9.2 (15.3)
Control patients 1059 63.9 (6.6) 28.7 (4.7) 83.2 52.1 7.4 9.1 (15.0)

* The numbers of case patients and control patients are the maximum numbers for whom fatty acid measurements were available, and numbers varied by fatty acid. BMI = body mass index; CARET = Carotene and Retinol Efficacy Trial; EPIC = European Prospective Investigation into Cancer and Nutrition; MCCS = Melbourne Collaborative Cohort Study; MEC = Multiethnic Cohort; N/A = data not available for this study; PCPT = Prostate Cancer Prevention Trial; PHS = Physicians’ Health Study; SELECT Selenium and Vitamin E Cancer Prevention Trial.